MERCK & CO, INC. for MERCK & CO INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2017 | $1,720,000 | Replaced |
| 1st Quarter - Amendment | Jul 20, 2017 | $1,720,000 | Yes |
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Animals ANI
Issues related to establishment of FMD vaccine bank.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN POLAK | — |
Trade (domestic/foreign) TRD
Issues related to international trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE OPPENHEIM | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill), House Republican tax blueprint, international tax proposals (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Copyright/Patent/Trademark CPT
Patent reform; Legislative issues related to Pharmaceutical patent issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE OPPENHEIM | — |
Health Issues HCR
340B (no specific bill), Hepatitis C (general education; no specific bill), Human papilloma virus and vaccine policies (general education; first dollar coverage; preventative services), shingles vaccine policies (general education), antimicrobial resistance (general education), biosimilars (no specific bill), cost and value of medicines (no specific bill), women's health (general education), Prescription Drug User Fee Act (PDUFA; general education), Affordable Care Act, general pharmaceutical issues (transparency, formulary design, prescription drug coverage), H.R. 1628 - American Health Care Act of 2017, Implementation of P.L.114-255 - 21st Century Cures Act, S.204/H.R.878 - Trickett Wendler Right to Try Act of 2017, S. 469 - Affordable and Safe Prescription Drug Importation Act, S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES CAREY | — |
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Medicare/Medicaid MMM
Medicare Part D (general education, no specific bill), changes to low-income subsidy structure in Medicare Part D (general education, no specific bill), H.R. 5122 (Centers for Medicare and Medicaid Innovation Part B demo), Independent Payment Advisory Board (general education, no specific bill), Medicare Part B (general education); Medicaid (no specific bill); Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; Cost and value of prescription drugs; Vaccines for Children Program, Part B Drug Demonstration Proposed Rule; Medicare access to DXA services; Hospital Outpatient Prospective Payment proposed rule (CMS).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Budget/Appropriations BUD
H.R. 2028 (continuing resolution to fund the federal government); S. Con. Res. 3 (Senate Budget Resolution 2017) - prescription drug policies. FY2017/FY2018, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; FY2017/FY2018, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2017/FY2018, Department of Defense Appropriations; Tricare formulary, reimbursement and vial size issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENELLE KRISHNAMOORTHY | — |
| COURTNEY LEE-ASHLEY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.